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IMPORTANCE The Third International Consensus Definitions Task Force defined sepsis
as “life-threatening organ dysfunction due to a dysregulated host response to infection.”
The performance of clinical criteria for this sepsis definition is unknown.
OBJECTIVE To evaluate the validity of clinical criteria to identify patients with suspected
infection who are at risk of sepsis.
DESIGN, SETTINGS, AND POPULATION Among 1.3million electronic health record encounters
from January 1, 2010, to December 31, 2012, at 12 hospitals in southwestern Pennsylvania, we
identified those with suspected infection in whom to compare criteria. Confirmatory analyses
were performed in 4 data sets of 706 399 out-of-hospital and hospital encounters at 165 US
and non-US hospitals ranging from January 1, 2008, until December 31, 2013.
EXPOSURES Sequential [Sepsis-related]OrganFailureAssessment (SOFA) score, systemic
inflammatory response syndrome (SIRS) criteria, LogisticOrganDysfunctionSystem (LODS)
score, andanewmodel derivedusingmultivariable logistic regression in a split sample, thequick
Sequential [Sepsis-related]OrganFailureAssessment (qSOFA) score (range,0-3points,with 1
point each for systolic hypotension [100mmHg], tachypnea [22/min], or alteredmentation).
MAIN OUTCOMES ANDMEASURES For construct validity, pairwise agreement was assessed.
For predictive validity, the discrimination for outcomes (primary: in-hospital mortality;
secondary: in-hospital mortality or intensive care unit [ICU] length of stay3 days) more
common in sepsis than uncomplicated infection was determined. Results were expressed as
the fold change in outcome over deciles of baseline risk of death and area under the receiver
operating characteristic curve (AUROC).
RESULTS In the primary cohort, 148907 encounters had suspected infection (n = 74453
derivation; n = 74454 validation), ofwhom6347 (4%) died. Among ICU encounters in the
validation cohort (n = 7932with suspected infection, ofwhom 1289 [16%] died), the predictive
validity for in-hospitalmortalitywas lower for SIRS (AUROC = 0.64; 95%CI, 0.62-0.66) and
qSOFA (AUROC = 0.66; 95%CI, 0.64-0.68) vs SOFA (AUROC = 0.74; 95%CI, 0.73-0.76;
P < .001 for both) or LODS (AUROC = 0.75; 95%CI, 0.73-0.76; P < .001 for both). Among
non-ICU encounters in the validation cohort (n = 66522with suspected infection, ofwhom
1886 [3%] died), qSOFAhad predictive validity (AUROC = 0.81; 95%CI, 0.80-0.82) thatwas
greater than SOFA (AUROC = 0.79; 95%CI, 0.78-0.80; P < .001) and SIRS (AUROC = 0.76; 95%
CI, 0.75-0.77; P < .001). Relative to qSOFA scores lower than 2, encounterswith qSOFA scores of
2 or higher had a 3- to 14-fold increase in hospitalmortality across baseline risk deciles. Findings
were similar in external data sets and for the secondary outcome.
CONCLUSIONS AND RELEVANCE Among ICU encounters with suspected infection, the
predictive validity for in-hospital mortality of SOFAwas not significantly different than the
more complex LODS but was statistically greater than SIRS and qSOFA, supporting its use in
clinical criteria for sepsis. Among encounters with suspected infection outside of the ICU, the
predictive validity for in-hospital mortality of qSOFAwas statistically greater than SOFA and
SIRS, supporting its use as a prompt to consider possible sepsis.
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A lthough common and associated with high morbidityandmortality,1,2 sepsis and related terms remain diffi-cult to define. Two international consensus confer-
ences in 1991and2001usedexpertopinion togenerate thecur-
rentdefinitions.3,4However, advances in theunderstandingof
thepathobiology andappreciation that elements of thedefini-
tions may be outdated, inaccurate, or confusing prompted
the European Society of
Intensive Care Medicine
and the Society of Critical
CareMedicine to convene
a Third International Con-
sensus Task Force to re-
examine the definitions.
Like many syndromes,
there is no “gold stan-
dard” diagnostic test for
sepsis. Therefore, the task
force chose several meth-
ods toevaluate theuseful-
ness of candidate clinical criteria, including clarity, reliability
(consistency and availability), content validity (biologic ratio-
nale and face validity), construct validity (agreement between
similar measures), criterion validity (correlation with estab-
lished measures and outcomes), burden, and timeliness. Un-
like prior efforts, the task force used systematic literature re-
views and empirical data analyses to complement expert
deliberations.
Based on clarity and content validity and after literature
review and expert deliberation, the task force recommended
elimination of the terms sepsis syndrome, septicemia, and se-
vere sepsis and instead defined sepsis as “life-threatening or-
gan dysfunction due to a dysregulated host response to
infection.”5Of note, the task force did not attempt to redefine
infection. Rather, it next sought to generate recommenda-
tions for clinical criteria that could be used to identify sepsis
among patients with suspected or confirmed infection. The
purposeof this studywas to informthis stepbyanalyzingdata
fromseveral large hospital databases to explore the construct
validity and criterion validity of existing andnovel criteria as-
sociated with sepsis.
Methods
This study was approved with waiver of informed consent by
the institutional reviewboards of theUniversity of Pittsburgh,
Kaiser Permanente Northern California (KPNC), Veterans Ad-
ministration (VA) AnnArborHealth System,Washington State
Department of Health, King County Emergency Medical Ser-
vices (KCEMS), University ofWashington, and Jena University
Hospital.
Study Design, Setting, and Population
A retrospective cohort studywas performed among adult en-
counters (age ≥18 years) with suspected infection. The pri-
mary cohort was all hospital encounters from 2010 to 2012 at
12 communityandacademichospitals in theUPMChealthcare
system in southwesternPennsylvania. The cohort includedall
medical and surgical encounters in the emergency depart-
ment, hospital ward, and intensive care unit (ICU). We cre-
ated a randomsplit sample (50/50) fromtheUPMCcohort, the
derivation cohort for developing new criteria, and the valida-
tion cohort for assessment of new and existing criteria.
We also studied 4 external data sets: (1) all inpatient
encounters at 20KPNChospitals from2009 to 2013; (2) all en-
counters in 130 hospitals in the United States’ VA system
from 2008 to 2010; (3) all nontrauma, nonarrest emergency
medical services records from 5 advanced life support agen-
cies from2009-2010 transported to 14 hospitalswith commu-
nity infection inKingCounty,Washington (KCEMS)6; and (4)all
patients from 2011-2012 at 1 German hospital enrolled with
hospital-acquired infection in the ALERTS prospective cohort
study.7 These cohortswere selectedbecause they includedpa-
tientencounters fromdifferentphasesofacutecare (outofhos-
pital, emergency department, hospital ward) and countries
(United States and Germany) with different types of infection
(community and nosocomial). The UPMC, KPNC, and VA data
wereobtained fromtheelectronichealth records (EHRs) of the
respectivehealthsystems;KCEMSdatawereobtained fromthe
administrative out-of-hospital record; and ALERTS data were
collected prospectively by research coordinators.
Defining a CohortWith Suspected Infection
For EHR data (UPMC, KPNC, and VA), the first episode of sus-
pected infectionwas identified as the combinationof antibiot-
ics (oral orparenteral) andbody fluidcultures (blood,urine, ce-
rebrospinal fluid, etc).We required the combination of culture
and antibiotic start time to occurwithin a specific time epoch.
If theantibioticwasgiven first, theculture samplingmusthave
beenobtainedwithin24hours. If theculturesamplingwasfirst,
theantibioticmusthavebeenorderedwithin72hours.The“on-
set” of infection was defined as the time at which the first of
these 2 events occurred (eAppendix in the Supplement). For
non-EHR data in ALERTS, patients were included who met
US Centers for Disease Control and Prevention definitions or
clinical criteria for hospital-acquired infection more than 48
hoursafteradmissionasdocumentedbyprospectivescreening.7
For non-EHR data in KCEMS, administrative claims identified
infection present on admission (Angus implementation of in-
fection using International Classification of Diseases, Ninth Re-
vision, Clinical Modification (ICD-9-CM) diagnosis codes).6
DeterminingClinical Criteria forSepsisUsingExistingMeasures
In UPMC derivation and validation data, indicators were gen-
erated for each component of the systemic inflammatory re-
sponse syndrome (SIRS) criteria4; the Sequential [Sepsis-
related] Organ Failure Assessment (SOFA) score8; and the
Logistic Organ Dysfunction System (LODS) score,9 a weighted
organ dysfunction score (Table 1). We used amodified version
of the LODS score that did not contain urine output (because
ofpooraccuracy inrecordingonhospitalwardencounters),pro-
thrombin, or urea levels. The maximum SIRS criteria, SOFA
score, and modified LODS score were calculated for the time
window from48hours before to 24hours after the onset of in-
fection, aswell as oneachcalendarday.Thiswindowwasused
EHR electronic health record
GCS Glasgow Coma Scale
ICU intensive care unit
LODS Logistic Organ Dysfunction
System
qSOFA quick Sequential
[Sepsis-related] Organ Function
Assessment
SIRS systemic inflammatory
response syndrome
SOFA Sequential [Sepsis-related]
Organ Function Assessment
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for candidate criteria because organdysfunction in sepsismay
occur prior to, near the moment of, or after infection is recog-
nized by clinicians or when a patient presents for care. More-
over, the clinical documentation, reporting of laboratory val-
ues in EHRs, and trajectory of organ dysfunction are
heterogeneousacrossencounters andhealth systems. Inapost
hocanalysis requestedby the task force, achange inSOFAscore
was calculated of 2 points or more from up to 48 hours before
to up to 24 hours after the onset of infection.
Deriving Novel Clinical Criteria for Sepsis
In the derivation cohort (UPMC), new, simple criteriawere de-
velopedaccording to theTransparentReportingof aMultivari-
able Prediction Model for Individual Prognosis or Diagnosis
(TRIPOD) recommendations.10This entailed2steps: (1) assess-
ingcandidatevariablequalityandfrequencyofmissingdataand
(2)developingaparsimoniousmodelandsimplepointscore.3,8,11
Becauseof the subjectivenatureandcomplexityofvariables in
existing criteria,we sought a simplemodel that could easily be
used by a clinician at the bedside.
Based on the assumption that hospitalmortalitywould be
farmorecommoninencounterswithinfectedpatientswhohave
sepsis than in thosewho do not, all continuous variables were
dichotomizedbydefining their optimal cutoffsusing themini-
mum0/1distanceontheareaunder thereceiveroperatingchar-
acteristiccurve(AUROC)for in-hospitalmortality.12Cutoffswere
rounded to the nearest integer, and standard single-value im-
putationwas used,with normal value substitution if variables
were missing. The latter approach is standard in clinical risk
scores8,13,14 andmirrors how clinicians would use the score at
the bedside. Multiple logistic regressionwas usedwith robust
standard errors and forward selection of candidate variables
using theBayesian information criterion todevelop the “quick
SOFA” (qSOFA)model. The Bayesian information criterion is a
likelihood-based stepwise approach that retains variables that
improve the model’s overall ability to predict the outcome of
interest while incorporating a penalty for including too many
variables. Favoring simplicity over accuracy, a point score of 1
was assigned to each variable in the final model, irrespective
of the regression coefficients. Model calibration was assessed
by comparing clinically relevant differences in observedvs ex-
pected outcomes, as the Hosmer-Lemeshow test may be sig-
nificant due to large sample sizes.15
Assessments of Candidate Clinical Criteria
Thetest:retestor interrater reliabilityof individualelementswas
not assessed, in part becausemost elements have known reli-
ability. However, the frequency of missing data was deter-
mined for each element because more common missing data
for individual elements will potentially affect the reliability of
integratedscoressuchas theSOFAscore.Constructvaliditywas
determined by examining the agreement between different
measures analogous to themultitrait-multimethodmatrix ap-
proach of Campbell and Fiske, using the Cronbach α to mea-
sureagreementor commonality.16,17Confidence intervalswere
generated with the bootstrapmethod (100 replications).
Criterion validity was assessed using the predictive valid-
ity of the candidate criteria with outcomes (primary outcome:
in-hospital mortality; secondary outcome: in-hospital mortal-
ityor intensivecareunit [ICU] lengthofstay≥3days).Theseout-
comes are objective, easily measured across multiple hospi-
tals in US/non-US cohorts, and aremore likely to be present in
encounters with patients with sepsis than those with uncom-
plicated infection.Tomeasurepredictivevalidity,abaselinerisk
modelwas created for in-hospitalmortality basedonpreinfec-
tion criteria using multivariable logistic regression. The base-
linemodel included age (as a fractional polynomial), sex, race/
ethnicity (black, white, or other), and the weighted Charlson
comorbidity score (as fractional polynomial) as a measure of
chronic comorbidities.18,19 Race/ethnicity was derived from
UPMC registration system data using fixed categories consis-
tent with the Centers for Medicare & Medicaid Services EHR
Table 1. Variables for Candidate Sepsis Criteria Among EncountersWith Suspected Infection
Systemic
Inflammatory
Response Syndrome
(SIRS) Criteria
(Range, 0-4 Criteria)
Sequential
[Sepsis-related] Organ Failure
Assessment (SOFA)
(Range, 0-24 Points)
Logistic Organ Dysfunction
System (LODS)
(Range, 0-22 Points)a
Quick Sequential
[Sepsis-related] Organ Failure
Assessment (qSOFA)
(Range, 0-3 Points)
Respiratory rate,
breaths per minute
PaO2/FiO2 ratio PaO2/FiO2 ratio Respiratory rate, breaths
per minute
White blood cell
count, 109/L
Glasgow Coma Scale score Glasgow Coma Scale score Glasgow Coma Scale score
Bands, % Mean arterial pressure, mm Hg Systolic blood pressure, mm Hg Systolic blood pressure, mm Hg
Heart rate, beats
per minute
Administration of vasopressors
with type/dose/rate of infusion
Heart rate, beats per minute
Temperature, °C Serum creatinine, mg/dL,
or urine output, mL/d
Serum creatinine, mg/dL
Arterial carbon
dioxide tension,
mm Hg
Bilirubin, mg/dL Bilirubin, mg/dL
Platelet count, 109/L Platelet count, 109/L
White blood cell count, 109/L
Urine output, L/d
Serum urea, mmol/L
Prothrombin time,
% of standard
Abbreviation: FiO2, fraction of
inspired oxygen.
a Measurement units for LODS
variables per original description by
Le Gall et al.9
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meaningful use data set.20 Race/ethnicity was included in the
baselinemodelbecauseof itsdescribedassociationwith the in-
cidence and outcomes of sepsis.21
Encounterswere thendivided intodeciles of baseline risk.
Within each decile, the rate of in-hospital mortality ± ICU
length of stay of 3 days or longer was determined comparing
encounters with infection with 2 or more SIRS, SOFA, LODS,
andqSOFApoints vs encounterswith less than2 criteria of the
same score (threshold of 2 points was determined a priori).
Model discrimination was assessed with the AUROC for each
outcome using the continuous score(s) alone, then added to
the baseline riskmodel. Analyses were separately performed
in ICU encounters and non-ICU encounters at the onset of in-
fection. New, simple criteria in external data sets were as-
sessed in both ICU and non-ICU encounters.
Because serum lactate is widely used as a screening tool
in sepsis,22howitsmeasurementwould improvepredictiveva-
lidity of newcriteriawas assessed inpost hoc analyses. Evalu-
ation included qSOFAmodels that did and did not include se-
rum lactate at thresholds of 2.0, 3.0, and 4.0 mmol/L (18, 27,
and36mg/dL) andas a continuousvariable.23OnlyKPNCdata
were used for these analyses because an ongoing quality im-
provement program promoting frequent serum lactate mea-
surementacross thehealth systemminimizedconfoundingby
indication.24
Several sensitivity analyses were performed to assess ro-
bustness of the findings. These included a variety of restric-
tions to the cohort, more rigorous definitions of suspected or
presumed infection, alternativeways tomeasure clinical vari-
ables (suchas alteredmentation in theEHR), andmultiple im-
putation analyses for missing data. There are many possible
timewindows for criteria around the onset of infection. A va-
riety of windows differing from the primary analysis were
tested, including (1) 3hoursbefore to3hours after; (2) 12hours
before to 12hours after; and (3) restricting toonly the24hours
after the onset of infection. Detailed descriptions are in the
Supplement.
All analyses were performed with STATA software, ver-
sion 11.0 (Stata Corp). All tests of significance used a 2-sided
P ≤ .05. We considered AUROCs to be poor at 0.6 to 0.7, ad-
equate at 0.7 to 0.8, good at 0.8 to 0.9, and excellent at 0.9 or
higher.25
Results
Cohorts and Encounter Characteristics
At 177 hospitals in 5 US and non-US data sets between 2008
and 2013 (Table 2), 4 885 558 encounters were studied. In the
primarycohortof 1 309025records (UPMCderivationandvali-
dation; Figure 1), 148 907 encounters had suspected infec-
tion, most often presenting outside of the ICU (n = 133 139
[89%]).As shown inTable3, first infectionwascommonly sus-
pected within 48 hours of admission (86%), most often pre-
senting in the emergency department (44%) compared with
theward (33%) or ICU (11%), andmortality was low (4%). The
Table 2. Summary of Data Sets
Characteristics UPMCa KPNC VA ALERTS KCEMS
Years of cohort 2010-2012 2009-2013 2008-2010 2011-2012 2009-2010
No. of hospitals 12 20 130 1 14
Total No. of encounters 1 309 025 1 847 165 1 640 543 38 098 50 727
Data source
and study design
Retrospective study
of EHRs
Retrospective study of
EHRs
Retrospective study
of EHRs
Prospective cohort
study
Retrospective study
of administrative records
Setting Integrated health
system in southwestern
Pennsylvania
Integrated health
system in northern
California
All hospitals in the US
VA system
Single university
hospital, Jena,
Germany
Out-of-hospital records
from integrated
emergency medical
services system in King
County, Washington
Definition of suspected
infection
Combination of body
fluid culture and
nonprophylactic
antibiotic administration
in the EHRb
Combination of body
fluid culture and
nonprophylactic
antibiotic administration
in the EHRb
Combination of body
fluid culture and
nonprophylactic
antibiotic administration
in the EHRb
CDC criteria
for hospital-acquired
infectionsc
ICD-9-CM codes
for infection, with
present-on-admission
indicatorsd
No. with suspected
infection (% of total)
148 907 (11) 321 380 (17) 377 325 (23) 1186 (3) 6508 (13)
Location at onset of
infection, No. (%) infected
Intensive care unit 15 768 (11) 7031 (2) 73 264 (19) 300 (25) 0
Outside of intensive
care unit
133 139 (89) 314 349 (98) 304 061 (81) 886 (75) 6508 (100)
In-hospital mortality,
No. (%) infectede
6347 (4) 16 092 (5) 22 593 (6) 210 (18) 700 (11)
Abbreviations: KCEMS, King County EmergencyMedical Services; KPNC, Kaiser
Permanente Northern California; EHR, electronic health record; ICD-9-CM,
International Classification of Diseases, Ninth Revision, Clinical Modification;
VA, Veterans Administration.
a Referred to as the primary cohort, further divided into derivation (n = 74 453)
and validation (n = 74 454) cohorts.
b See the eAppendix in the Supplement for details about time windows
specified between body fluid cultures and antibiotic administration.
c Patients were enrolled in ALERTS if the in-hospital stay was longer than
48 hours and in-person prospective screening revealed hospital-acquired
infection criteria according to Centers for Disease Control and Prevention
(CDC) guidelines.7
dRequired Angus implementation ICD-9-CM code for infection accompanied
by present-on-admission indicator, as previously validated.6
e Among UPMC encounters, 28 286 (19%) had in-hospital mortality plus
intensive care unit length of stay of 3 days or longer.
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median time from the start of the encounter until the onset of
suspected infection (definedascultureorantibioticsorder)was
4.2 hours (interquartile range, 1.6-19.2 hours). In KPNC hos-
pitals (eTable 1 in the Supplement), first suspected infections
occurredoutside the ICU (98%)withsimilarmortality (5%)and
proportion identifiedwithin 48hours of admission (81%). Se-
rum lactate was measured in 57% of suspected infection en-
counters in KPNC hospitals compared with less than 10% in
the other cohorts. In VA hospitals, encounters with sus-
pected infectionhadsimilarmortality (6%)butweremore likely
to be first identified in the ICU (19%). Aminority of first infec-
tion episodes occurred following surgery, and positive blood
cultures were found in 5% to 19% of encounters. In the base-
line risk model, using only demographics and comorbidities,
there was a 10-fold variation for in-hospital mortality across
deciles of baseline risk, ranging from0.7% to 8% (eFigure 1 in
the Supplement).
Frequency ofMissing Data Among Clinical
and Laboratory Variables
In theUPMCderivationcohort, SIRS criteria andselected labo-
ratory tests in SOFA and LODSwere variablymeasured in the
EHR near the onset of infection (eFigure 2 in the Supple-
ment). Tachycardia, tachypnea, and hypotension, although
present in less than 50% of encounters, were the most com-
mon clinical abnormalities. Encounters in the ICUweremore
likely to have SIRS and SOFA variables measured and values
weremore likely tobeabnormal. For encountersoutsideof the
ICU, laboratory data were less available, with total bilirubin,
ratioofPaO2 to fractionof inspiredoxygen, andplatelet counts
absent in 62%, 74%, and 15% of encounters, respectively.
Performance of Existing Criteria in the ICU
in the UPMC Cohort
Among ICUencounterswith suspected infection in theUPMC
validation cohort (n = 7932 [11%]), most had 2 or more LODS
points (88%), SOFA points (91%), or SIRS criteria (84%) near
the timeof suspected infection,withmortality ratesof 18%for
all scoresat this threshold (Figure2andeFigure3 in theSupple-
ment). SOFAandLODShad greater statistical agreementwith
each other (α = 0.87; 95% CI, 0.87-0.88) but lower with SIRS
(α = 0.43 [95%CI, 0.41-0.46] for SOFA; α = 0.41 [95%CI, 0.38-
0.43] forLODS) (Figure3).Encounters in the ICUwith2ormore
vs less than2SIRScriteriawerecomparedwithindecileofbase-
line risk and observed a 1- to 2-fold increased rate of hospital
mortality compared with a 3- to 11-fold increase in mortality
comparing those with 2 or more vs less than 2 SOFA points
(Figure4). The fold change in theLODS scorewas evengreater
than that for SOFA.
In the ICU, the predictive validity for hospital mortality
using SOFA (AUROC = 0.74; 95% CI, 0.73-0.76) and LODS
(AUROC = 0.75; 95% CI, 0.73-0.76; P = .20) were not statisti-
cally different but were statistically greater than that of SIRS
(AUROC = 0.64; 95% CI, 0.62-0.66; P < .001 for either LODS
or SOFA vs SIRS) (Figure 3 and eFigure 4 and eTable 2 in the
Supplement). Results for a change in SOFAof 2points ormore
were significantlygreater comparedwithSIRS (AUROC = 0.70;
95% CI, 0.68-0.71; P < .001 vs SIRS criteria). The SOFA score
was2ormore in98%ofdecedents (95%CI, 97%-99%); among
survivors, theSOFAscorewas less than2 in 10%(95%CI, 10%-
11%). These proportions were similar for a LODS threshold of
2 or 3 (eTable 3 in the Supplement). Among decedents, 2 or
moreSIRScriteriawerepresent in91%(95%CI, 89%-92%).Re-
sults were consistent for the combined outcome (eFigures 5
and 6 in the Supplement).
Performance of Existing Criteria Outside the ICU
in the UPMC Cohort
For encounters with suspected infection outside of the ICU
(n = 66522 [89% of cohort]), 20 130 (30%) had no SIRS crite-
ria, 27 560 (41%) had no SOFA points, and 29789 (45%) had
noLODSpoints (Figure2).Agreement followedapattern simi-
Figure 1. Accrual of Encounters for Primary Cohort
1 309 025 Patient encounters at 12 UPMC
hospitals in 2010-2012
148 907 With suspected infection in ED,
ICU, ward, step-down unit, or
PACU included in primary cohort
1 160 118 Excluded
1 109 402 No infection present
2117 Error in encounter start time
45 628 Aged <18 y
2169 Outside eligible date range
28 Error in hospital type
774 Initial location was clinic
74 453 Included in derivation cohort 74 454 Included in validation cohort
66 617 Outside of ICU7836 In ICU 66 522 Outside of ICU7932 In ICU
ED indicates emergency department;
ICU, intensive care unit;
PACU, postanesthesia care unit.
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lar to that in the ICU encounters but with generally smaller
Cronbach α statistics (Figure 3). Over deciles of baseline risk
(Figure 4), encounters with 2 or more vs less than 2 SIRS cri-
teria had a 2- to 7-fold increase in the rate of in-hospital mor-
tality comparedwith up to an 80-fold change for 2 ormore vs
less than 2 SOFA points.
Table 3. Characteristics of EncountersWith Suspected Infection in the Primary Cohort at 12 UPMCHospitals From 2010 to 2012 (N = 148907)a
Variables All Encounters
Derivation Cohort Validation Cohort
ICU Encounters
Encounters Outside
of ICU ICU Encounters
Encounters Outside
of ICU
Total encounters with suspected
infection, No.
148 907 7836 66 617 7932 66 522
Infection type, No. (%)b
Presumed 112 850 (76) 7282 (93) 49 287 (74) 7351 (93) 48 930 (74)
Confirmed bacteremia 6875 (5) 646 (8) 2780 (4) 652 (8) 2797 (4)
Age, mean (SD), y 61 (19) 62 (17) 61 (20) 62 (17) 60 (20)
Male, No. (%) 63 311 (43) 4192 (54) 27 418 (41) 4255 (54) 27 446 (41)
Race/ethnicity, No. (%)
White 113 029 (76) 5774 (74) 50 843 (76) 5881 (74) 50 531 (76)
Black 20 892 (14) 808 (10) 9552 (14) 777 (10) 9755 (15)
Other 14 986 (10) 1254 (16) 6222 (9) 1274 (16) 6236 (9)
Weighted Charlson comorbidity index,
median (IQR)
1 (0-2) 1 (0-2) 1 (0-2) 1 (0-2) 1 (0-2)
Surgery prior to infection suspected,
No. (%)
17 327 (12) 2153 (27) 6517 (10) 2171 (27) 6486 (10)
Onset of infection within 48 h
of admission, No. (%)
128 358 (86) 6022 (77) 58 187 (87) 5993 (76) 58 156 (87)
Unit location at time infection suspected,
No. (%)
Emergency department 65 934 (44) 32 902 (50) 33 032 (50)
Ward 49 354 (33) 24 787 (37) 24 567 (37)
ICU 15 768 (11) 7836 (100) 7932 (100)
Postacute care unit or procedure unit 1965 (1) 960 (1) 1005 (2)
Step-down unit 15 662 (11) 7855 (12) 7807 (12)
Other or missing data 224 (<1) 113 (<1) 111 (<1)
SIRS near onset of suspected infectionc
Mean (SD) 1.3 (1.1) 2.5 (1.0) 1.2 (1.1) 2.5 (1.0) 1.2 (1.0)
Median (IQR) 1 (0-2) 3 (2-3) 1 (0-2) 3 (2-3) 1 (0-2)
SOFA near onset of suspected infectiond
Mean (SD) 2.0 (2.7) 6.3 (4.0) 1.4 (1.9) 6.2 (3.9) 1.4 (2.0)
Median (IQR) 1 (0-3) 6 (3-9) 1 (0-2) 6 (3-9) 1 (0-2)
LODS near onset of suspected infectione
Mean (SD) 2.0 (2.8) 6.3 (3.9) 1.5 (2.1) 6.3 (3.8) 1.5 (2.1)
Median (IQR) 1 (0-3) 6 (4-9) 1 (0-3) 6 (3-9) 1 (0-3)
Serum lactate measured on day
of infection, No. (%)
13 492 (9) 3187 (41) 3611 (5) 3067 (39) 3627 (5)
Serum lactate ≥2.0 mmol/L, No. (%) 6177 (4) 1643 (21) 1444 (2) 1555 (20) 1535 (2)
ICU admission, No. (%) 37 528 (25) 7836 (100) 10 935 (16) 7932 (100) 10 825 (16)
Hospital length of stay, median (IQR), d 6 (3-10) 12 (7-20) 6 (3-9) 12 (7-19) 6 (3-9)
Hospital mortality, No. (%) 6347 (4) 1298 (17) 1874 (3) 1289 (16) 1886 (3)
SI conversion: To convert serum lactate tomilligramsper deciliter, divide by0.111.
Abbreviations: ICU, intensive care unit; IQR, interquartile range; LODS, Logistic
Organ Dysfunction System; SIRS, systemic inflammatory response syndrome;
SOFA, Sequential [Sepsis-related] Organ Function Assessment.
a Data derived from electronic health records.
b Presumed infection is a subset of suspected infection in which encounters
received 2 or more doses of an antibiotic within 96 hours of onset of infection.
Confirmed bacteremia is a subset among which blood cultures were positive
during the encounter.
c SIRS criteria range from0 to 4, wherein 1 point is given for perturbations of the
following variables: respiratory rate, white blood cell count/bands, heart rate,
and temperature (see Table 1).29 Maximum score is determined from 48 hours
before to 24 hours after onset of infection.
d The SOFA score ranges from0 to 24, where 0 to 4 points are assigned for 1 of
6 organ dysfunctions: hematologic, hepatic, respiratory, neurologic, cardiac,
and renal.8 A greater score corresponds to greater severity. Maximum score is
determined from 48 hours before to 24 hours after onset of infection.
e The LODS score, modified for available data, ranges from0 to 22 points,
wherein points are assigned with increasing severity to hematologic, hepatic,
pulmonary, neurologic, cardiovascular, and renal dysfunction.9 Maximum
score is determined from 48 hours before to 24 hours after onset of infection.
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Figure 2. Distribution of Patient Encounters Over SIRS Criteria and SOFA, LODS, and qSOFA Scores Among ICU Patients and Non-ICU Patients
With Suspected Infection in the UPMCValidation Cohort (N = 74454)
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ICU indicates intensive care unit; LODS, Logistic Organ Dysfunction System;
qSOFA, quick Sequential [Sepsis-related] Organ Function Assessment; SIRS,
systemic inflammatory response syndrome; SOFA, Sequential [Sepsis-related]
Organ Function Assessment. The x-axis is the score range, with LODS truncated
at 14 points (of 22 points) and SOFA truncated at 16 points (of 24 points) for
illustration.
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The discrimination of hospital mortality using SOFA
(AUROC = 0.79;95%CI,0.78-0.80),LODS(AUROC = 0.82;95%
CI,0.81-0.83), or change inSOFA (AUROC = 0.79;95%CI,0.78-
0.79) scoreswas significantly greater comparedwith SIRS cri-
teria (AUROC = 0.76;95%CI,0.75-0.77;P < .01 for all) (Figure3
andeFigure4andeTable2 in theSupplement). Sixty-eightper-
cent (95% CI, 66%-70%) of decedents had 2 or more SOFA
points and 67% (95%CI, 66%-67%) of survivors had less than
2 SOFA points. In comparison, only 64% (95% CI, 62%-67%)
of decedents had 2 ormore SIRS criteria, whereas 65%of sur-
vivors had less than2SIRS criteria (95%CI, 64%-65%) (eTable
3 in the Supplement). Results were consistent for the com-
bined outcome (eFigures 5 and 6 in the Supplement).
Performance of New, Simple Criteria
The final qSOFA model included Glasgow Coma Scale (GCS)
scoreof 13or less, systolicbloodpressureof 100mmHgor less,
and respiratory rate of 22/min or more (1 point each; score
range, 0-3) (Table 4). Most encounters with infection (73%-
90%)had less than2qSOFApoints, andmortality ranged from
1% to 24%over the score range (eFigure 7 in the Supplement).
Calibration plots showed similar observed vs expected pro-
portionofdeathsacrossqSOFAscores (eFigure8 in theSupple-
ment). The qSOFA agreed reasonably well with both SOFA
(α = 0.73; 95%CI,0.73-0.74) andLODS (α = 0.79; 95%CI,0.78-
0.79) and, unlike SOFAandLODS, also agreedmorewith SIRS
(α = 0.69; 95% CI, 0.68-0.69) (Figure 3). The 24% of encoun-
terswith infectionwith2or 3qSOFApoints accounted for 70%
of deaths, 70% of deaths or ICU stays of 3 days or longer.
In the ICU, the predictive validity for hospital mortality of
qSOFA above baseline risk (AUROC = 0.66; 95% CI, 0.64-
0.68) was statistically greater than SIRS criteria (P = .01) but
significantly less than SOFA (P < .001) (Figure 3 and eFigure 4
and eTable 2 in the Supplement). Outside of the ICU, there
was a 3- to 14-fold increase in the rate of hospital mortality
across the entire range of baseline risk comparing those with
2 or more vs less than 2 qSOFA points (Figure 4). The predic-
tive validity of qSOFA was good for in-hospital mortality
(AUROC = 0.81; 95% CI, 0.80-0.82), was not statistically dif-
ferent from LODS (P = .77) and was statistically greater than
SOFA or change in SOFA score (P < .001 for both) (Figure 3,
Figure 4, and eFigure 4 and eTable 2 in the Supplement). Sev-
enty percent (95% CI, 69%-72%) of decedents had 2 or more
qSOFA points and 78% (95% CI, 78%-79%) of survivors had
less than 2 qSOFA points (eTable 3 in the Supplement).
Results were consistent for the combined outcome (eFigures
5 and 6 in the Supplement).
Amongencounterswith2ormoreqSOFApoints, 75%also
had2ormoreSOFApoints (eFigure9 in theSupplement). This
proportion was greater among decedents (89%) and ICU en-
counters (94%) and increased as the time window for evalu-
ationwas extended to 48 hours (90%) and 72 hours (92%) af-
ter the onset of infection.
External Data Sets
The qSOFA was tested in 4 external data sets comprising
706 399 patient encounters at 165 hospitals in out-of-
hospital (n = 6508),non-ICU(n = 619 137), and ICU(n = 80595)
Figure 3. Area Under the Receiver Operating Characteristic Curve and 95%Confidence Intervals for In-Hospital Mortality of Candidate Criteria
(SIRS, SOFA, LODS, and qSOFA) Among Suspected Infection Encounters in the UPMCValidation Cohort (N = 74454)
ICU encounters (n = 7932) A
SIRS 0.64
(0.62-0.66)
0.43
(0.41-0.46)
0.41
(0.38-0.43)
0.46
(0.43-0.48)
SOFA <.001 0.74(0.73-0.76)
0.87
(0.87-0.88)
0.65
(0.63-0.66)
LODS <.001 0.20 0.75(0.73-0.76)
0.76
(0.75-0.77)
qSOFA .01 <.001 <.001 0.66(0.64-0.68)
SIRS SOFA LODS qSOFA
Non-ICU encounters (n = 66 522) B
SIRS 0.76
(0.75-0.77)
0.52
(0.51-0.53)
0.43
(0.42-0.44)
0.61
(0.61-0.62)
SOFA <.001 0.79(0.78-0.80)
0.80
(0.80-0.81)
0.59
(0.58-0.60)
LODS <.001 <.001 0.81
(0.80-0.82)
0.68
(0.68-0.69)
qSOFA <.001 <.001 .72 0.81(0.80-0.82)
SIRS SOFA LODS qSOFA
ICU indicates intensive care unit; LODS, Logistic Organ Dysfunction System;
qSOFA, quick Sequential [Sepsis-related] Organ Function Assessment; SIRS,
systemic inflammatory response syndrome; SOFA, Sequential [Sepsis-related]
Organ Function Assessment. The area under the receiver operating
characteristic curve (AUROC) data in the blue-shaded diagonal cells derive from
models that include baseline variables plus candidate criteria. For comparison,
the AUROC of the baseline model alone is 0.58 (95% CI, 0.57-0.60) in the ICU
and 0.69 (95% CI, 0.68-0.70) outside of the ICU. Below the AUROC data cells
are P values for comparisons between criteria, while above the AUROC data
cells are Cronbach α data (with bootstrap 95% confidence intervals), a measure
of agreement.
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settings (eTable 1 in theSupplement). Amongencounterswith
community infection (KCEMS) or hospital-acquired infection
(ALERTS), qSOFA had consistent predictive validity
(AUROC = 0.71 and 0.75, respectively) (Table 5 and eFigure 4
in the Supplement). Results were similar in the VA data set
(AUROC = 0.78), in which no GCS data were available.
Serum Lactate
During model building in UPMC data, serum lactate did not
meetprespecifiedstatistical thresholds for inclusion inqSOFA.
In KPNC data, the post hoc addition of serum lactate levels of
2.0mmol/L (18mg/dL) ormore to qSOFA (revised to a 4-point
scorewith 1 added point for elevated serum lactate level) sta-
tisticallychangedthepredictivevalidityofqSOFA(AUROCwith
lactate = 0.80; 95% CI, 0.79-0.81 vs AUROC without lac-
tate = 0.79; 95% CI, 0.78-0.80; P < .001) (eFigure 10A in the
Supplement).AsshownineTable4 in theSupplement, thiswas
consistent for higher thresholds of lactate (3.0 mmol/L
[27mg/dL], 4.0mmol/L [36mg/dL]) orusinga continuousdis-
tribution (P < .001).However, the clinical relevancewas small
as the ratesof in-hospitalmortality comparingencounterswith
2 or more vs less than 2 points across deciles of risk were nu-
merically similar whether or not serum lactate was included
in qSOFA (eFigure 10B in the Supplement).
Among encounters with 1 qSOFA point but also a serum
lactate level of 2.0mmol/L ormore, in-hospitalmortalitywas
higher than that for encounters with serum lactate levels of
less than2.0mmol/L across the rangeofbaseline risk. The rate
of in-hospitalmortalitywasnumerically similar to that for en-
counters with 2 qSOFA points using the model without se-
rumlactate (eFigure 11 in theSupplement). Because serumlac-
tate levels are widely used for screening at many centers, the
distribution of qSOFA scores over strata of serum lactate level
was investigated. The qSOFA consistently identified higher-
risk encounters even at varying serum lactate levels (eFigure
12 in the Supplement).
Figure 4. Fold Change in Rate of In-Hospital Mortality (Log Scale) Comparing EncountersWith ≥2 vs <2 Criteria
for Each Decile of Baseline Risk in the UPMCValidation Cohort (N = 74454)
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ICU indicates intensive care unit;
LODS, Logistic Organ Dysfunction
System; qSOFA, quick Sequential
[Sepsis-related] Organ Function
Assessment; SIRS, systemic
inflammatory response syndrome;
SOFA, Sequential [Sepsis-related]
Organ Function Assessment. Panel A
shows ICU encounters comparing
fold change for SIRS, SOFA, LODS,
and qSOFA. Panel B shows non-ICU
encounters. Medians and ranges of
baseline risk of in-hospital mortality
within decile shown are below the
x-axis.
Interpretive example: The x-axis
divides the cohort into deciles of
baseline risk, determined by age, sex,
comorbidities, and race/ethnicity.
For a young womanwith no
comorbidities (panel A, decile 2)
admitted to the ICUwith pneumonia,
her chance of dying in the hospital is
10-fold greater if she has 3 SOFA
points compared with 1 SOFA point.
On the other hand, she has only a
small increase in the chance of dying
if she has 3 SIRS criteria compared
with 1 SIRS criterion. For an older
womanwith chronic obstructive
pulmonary disease admitted to the
ward with pneumonia (panel B, decile
6), her chance of dying in the hospital
is 7-fold higher if she has 3 qSOFA
points compared with 1 qSOFA point.
On the other hand, she has only a
3-fold increase in odds of dying if she
has 3 SIRS criteria compared with 1
SIRS criterion.
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TimeWindows forMeasuring qSOFA Variables
When qSOFA variables were measured in the time window
from3hours before/after or 12 hours before/after the onset of
infection in KPNC data (eTable 4 in the Supplement), results
werenot significantlydifferent fromtheoriginalmodel (P = .13
for 3 hours and P = .74 for 12 hours). When qSOFA variables
were restricted to only the 24-hour period after the onset of
infection, thepredictive validity for in-hospitalmortalitywas
significantly greater (AUROC = 0.83; 95% CI, 0.83-0.84;
P < .001) compared with the primary model.
Additional sensitivityanalysesare shown ineTable4 in the
Supplement. Thepredictive validity of qSOFAwasnot signifi-
cantlydifferentwhenusingmoresimplemeasures, suchasany
alteredmentation (GCS score <15 [P = .56] comparedwith the
modelwithGCSscore≤13).Thepredictivevaliditywasalsonot
significantly different when performed after multiple impu-
tation for missing data and in a variety of a priori subgroups.
Discussion
TheThird International ConsensusDefinitionsTaskForcede-
fined sepsis as a “life-threatening organ dysfunction due to a
dysregulated host response to infection.”5 In the absence of a
gold-standard test for sepsis, several domains of validity and
usefulnesswereused to assess potential clinical criteria to op-
erationalize this definition. Among encounters with sus-
pected infection in the ICU (Figure 3), SOFAandLODShad sta-
tisticallygreaterpredictivevaliditycomparedwithSIRScriteria.
Outside of the ICU, a simplemodel (qSOFA) of alteredmenta-
Table 5. AUROCs for In-Hospital Mortality for qSOFA in External Data Sets
Data Set and Infection Type
No. of Patients With
Suspected Infection
AUROC (95% CI)
Baseline Model Baseline Model + qSOFA
KPNC (all suspected infections) 321 380 0.67 (0.67-0.67) 0.78 (0.78-0.78)
ICU patients 7031 0.64 (0.62-0.66) 0.72 (0.70-0.73)
Non-ICU patients 314 349 0.68 (0.67-0.68) 0.78 (0.78-0.79)
VA (all suspected infections)a 377 325 0.73 (0.73-0.74) 0.78 (0.78-0.79)
ALERTS (hospital-acquired infections) 1186 0.55 (0.51-0.60) 0.73 (0.69-0.77)
KCEMS (community-acquired infections) 6508 0.59 (0.57-0.62) 0.71 (0.69-0.73)
Abbreviations: AUROC, area under the receiver operating characteristic curve;
ICU, intensive care unit; KCEMS, King County EmergencyMedical Services;
KPNC, Kaiser Permanente Northern California; qSOFA, quick Sequential
[Sepsis-related] Organ Function Assessment; VA, Veterans Administration.
a The VA data did not include Glasgow Coma Scale scores; the qSOFA is a
modified 2-variable model (systolic blood pressure and respiratory rate only),
with a range from0 to 2 points.
Table 4. Odds Ratios for BaselineModel and qSOFA Variables for In-Hospital Mortality in the UPMCDerivation
Cohort (N = 74453)
Total No. With
Categorical Variable
Deaths, No.
(% of Total)
In-Hospital Mortality, Adjusted
Odds Ratio (95% CI)
Baseline risk modela
Age, yb 1.03 (1.03-1.03)
Charlson comorbidity indexb 1.13 (1.11-1.15)
Race/ethnicity
White 56 617 2470 (4) 1 [Reference]
Black 10 360 319 (3) 0.89 (0.79-1.01)
Other 7476 383 (5) 1.37 (1.22-1.53)
Male
No 42 843 1467 (3) 1 [Reference]
Yes 31 610 1705 (5) 1.56 (1.45-1.68)
qSOFA modelc
Respiratory rate, /min
<22 45 398 676 (1) 1 [Reference]
≥22 29 055 2496 (9) 3.18 (2.89-3.50)
Systolic blood pressure, mm Hg
>100 44 669 789 (2) 1 [Reference]
≤100 29 784 2383 (8) 2.61 (2.40-2.85)
Altered mental status, Glasgow Coma
Scale score
14-15 66 879 1677 (3) 1 [Reference]
≤13 7574 1495 (20) 4.31 (3.96-4.69)
Abbreviations: qSOFA, quick
Sequential [Sepsis-related]
Organ Failure Assessment;
UPMC, University of Pittsburgh
School of Medicine.
a Fully parameterized using fractional
polynomials in final analyses.
bOdds ratios correspond to a
comparison between encounters
separated by 1 unit change in age or
Charlson comorbidity index score.
c Multivariable logistic regression
model of qSOFA variables illustrates
their association with in-hospital
mortality. The odds ratios compare
groups of encounters with vs
without the specified criteria.
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tion, lowsystolic bloodpressure, andelevated respiratory rate
hadstatistically greaterpredictivevalidity than theSOFAscore
(Figure3).ThepredictivevalidityofqSOFAwasrobust toevalu-
ationunder variedmeasurement conditions, in academic and
community hospitals, in international locations of care, for
community and hospital-acquired infections, and after mul-
tiple imputation for missing data. It was, however, statisti-
cally inferior compared with SOFA for encounters in the ICU
and has a statistically lower content validity as a measure of
multiorgan dysfunction. Thus, the task force recommended
use of a SOFA score of 2 points ormore in encounters with in-
fection as criteria for sepsis and use of qSOFA in non-ICU set-
tings to consider the possibility of sepsis.
Criteria Outside of the ICU
For infected patients outside of the ICU, there is an increasing
focus onearly recognitionof sepsis. Potential criteria for organ
dysfunction likeSOFAorLODSrequiredclinical and laboratory
variables thatmaybemissinganddifficult toobtain ina timely
manner.Thesecharacteristicsmay increasemeasurementbur-
den for clinicians. In comparison, a simplemodel (qSOFA)uses
3clinical variables,hasno laboratory tests, andhasapredictive
validity outside of the ICU that is statistically greater than the
SOFAscore (P < .001). TheqSOFAandSOFAscores alsohadac-
ceptable agreement in themajority of encounters.
However, 3 potentially controversial issues are worth not-
ing.First,qSOFAwasderivedandtestedamongpatientencoun-
ters inwhich infectionwasalreadysuspected.TheqSOFAisnot
analert thatalonewilldifferentiatepatientswith infection from
those without infection. However, at least in many US and
European hospital settings, infection is usually suspected
promptly, as evidenced by rapid initiation of antibiotics.26,27
Second,mental status is assessedvariably indifferent set-
tings, which may affect the performance of the qSOFA. Al-
though the qSOFA appeared robust in sensitivity analyses to
alternative GCS cut points, further work is needed to clarify
its clinical usefulness. In particular, themodel evaluatedonly
whether mental status was abnormal, not whether it had
changed frombaseline, which is extremely difficult to opera-
tionalize and validate, both in the EHR and as part of routine
charting. An alternative to the GCS (eg, Laboratory and Acute
PhysiologyScore,version2, inKPNCencounters)28 foundsimi-
lar results.
Third, serum lactate levels, which have been proposed as
a screening tool for sepsis or septic shock, were not retained
in the qSOFA during model construction. One reasonmay be
because serum lactate levelswerenotmeasured commonly in
the UPMC data set. When serum lactate levels were added to
qSOFA post hoc in the KPNC health system data set, in which
measurementof lactate levelswas common, thepredictiveva-
liditywasstatistically increasedbutwith littledifference inhow
encounters were classified. This analysis assessed only how
serum lactate levels at different thresholds contributed above
andbeyond theqSOFAmodel.However, among intermediate-
risk encounters (qSOFAscore = 1), the additionof a serum lac-
tate level of 2.0mmol/L (18mg/dL) or higher identified those
with a risk profile similar to thosewith 2 qSOFA points. Thus,
areas for further inquiry include whether serum lactate lev-
els could be used for patients with borderline qSOFA values
or as a substitute for individual qSOFA variables (particularly
mental status, given the inherent problemsdiscussed above),
especially in health systems in which lactate levels are reli-
ably measured at low cost and in a timely manner.
Criteria in the ICU
Among ICU encounters, the diagnosis of sepsis may be chal-
lenging because of preexisting organ dysfunction, treatment
prior toadmission,andconcurrentorgansupport. In this study,
as others have reported in a distinct geographic region and
health care system,29 traditional tools such as the SIRS crite-
ria have poor predictive validity among patients who are in-
fected. Yet in our study, SOFA and LODS scores had superior
predictive validity in the ICU and greater agreement, perhaps
because more variables were likely to be measured, abnor-
mal, and independent of ongoing interventions. These re-
sults are consistentwithprior studies of SOFAandLODS in the
ICU.30,31 On average, only 2 of 100 infected decedents in the
ICUhad a SOFAor LODS score of less than 2. The qSOFA score
had statisticallyworse predictive validity in the ICU, likely re-
lated to the confounding effects of ongoingorgan support (eg,
mechanical ventilation, vasopressors).
Advances Using EHRs
The data from these analyses provided the Third Interna-
tional Consensus Task Forcewith evidence about clinical cri-
teria for sepsis using EHRs from 3 large health systems with
both academic and community hospitals. More than 60% of
US nonfederal, acute care hospitals (and all US federal hospi-
tals) now use advanced EHRs. Adoption of EHRs has in-
creased 8-fold since 2009 in the United States and will con-
tinue to increase.32 The EHR may present hospitals with an
opportunity to rapidly validate criteria for patients likely to
have sepsis, to test prompts or alerts among infected patients
with specific EHRsignatures suggestive of sepsis, and tobuild
platforms for automated surveillance.33 In addition, criteria
such as in the qSOFA can bemeasured quickly and easily and
assessed repeatedly over time inpatients at risk of sepsis, per-
haps even in developing countries without EHRs.
Limitations
This investigationhasseveral limitations.First,westudiedonly
patients in whom infection was already suspected or docu-
mented.Wedidnot address how todiagnose infection among
those inwhomlife-threateningorgandysfunctionwas the ini-
tial presentation. Therefore, these data alone donotmandate
thathospitalizedpatientswithSOFAorqSOFApointsbeevalu-
ated for the presence of infection.
Second, we chose to develop simple criteria that clini-
cians could quickly use at the bedside, balancing timeliness
and content validity with greater criterion validity. We ac-
knowledge that predictive validity would be improved with
more complexmodels that include interaction terms or serial
measurements over time.3,34,35 We tested how the change in
SOFA score over timewould perform, and although similar to
the maximum SOFA score, the optimal time windows over
which change should be measured are not known.
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Third, no organ dysfunction measurements evaluated in
this study distinguish between chronic and acute organ dys-
function, assesswhether the organdysfunction has an expla-
nation other than infection, or attribute dysfunction specifi-
cally to a dysregulated host response. For example, a patient
withdementiawith an abnormalGCS score at baselinewill al-
ways have 1 qSOFApoint butmay not be as likely to have sep-
sis as a patientwith anormal baseline sensorium.As such,we
illustrated the predictive validity of various criteria across a
full rangeofunderlying riskdetermined fromcomorbidity and
demographics.
Fourth,we chose 2 outcomes associatedmore commonly
with sepsis than with uncomplicated infection. These out-
comeshavehighcontentvalidityandweregeneralizableacross
data sets, but there are certainly alternative choices.36
Fifth,we compared predictive validitywith tests of infer-
ence that may be sensitive to sample size. We found that sta-
tistically significant differences inAUROCwereoftenpresent,
yet these resulted in differences in classification with debat-
able clinical relevance.We reconciled these data by reporting
the fold change in outcome comparing encounters of differ-
ent scores to provide more clinical context.
Sixth, theacute, life-threateningorgandysfunction in sep-
sis may also occur at different times in different patients
(before,during,or after infection is recognized).37Resultswere
unchangedoveravarietyof timewindows, includingboth long
(72-hour) and short (6-hour)windows around the onset of in-
fection. Prospective validation in other cohorts, assessment
in low- to middle-income countries, repeated measurement,
and the contribution of individual qSOFA elements to predic-
tive validity are important future directions.
Conclusions
Among ICU encounters with suspected infection, the predic-
tive validity for in-hospital mortality of SOFAwas not signifi-
cantly different than the more complex LODS but was statis-
tically greater than SIRS and qSOFA, supporting its use in
clinical criteria for sepsis. Among encounters with suspected
infection outside of the ICU, the predictive validity for in-
hospitalmortalityofqSOFAwas statistically greater thanSOFA
and SIRS, supporting its use as a prompt to consider possible
sepsis.
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